| 10/06/2022 |
14:00 às 14:45 |
Módulo Câncer de Pele e Sarcomas |
14:15 às 14:20 |
9507 - Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers. |
Palestrante |
| 10/06/2022 |
14:00 às 14:45 |
Módulo Câncer de Pele e Sarcomas |
14:20 às 14:25 |
9515 - Atezolizumab (A), cobimetinib (C), and vemurafenib (V) in patients (pts) with BRAFV600 mutation–positive melanoma with central nervous system (CNS) metastases (mets): Primary results from phase 2 Tricotel study. |
Palestrante |
| 10/06/2022 |
14:00 às 14:45 |
Módulo Câncer de Pele e Sarcomas |
14:25 às 14:30 |
11505 - Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children’s Oncology Group study AEWS0031. |
Palestrante |
| 10/06/2022 |
14:00 às 14:45 |
Módulo Câncer de Pele e Sarcomas |
14:30 às 14:45 |
Painel de discussão |
Debatedor |
